| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Revenue | $1.44B | +5.2% |
| Cost of Revenue | $899.7M | -3.5% |
| Gross Profit | $541.8M | +23.8% |
| R&D Expense | $14.7M | +59.8% |
| SG&A Expense | $327.8M | +7.4% |
| Operating Income | $212.1M | +61.7% |
| Interest Expense | $56.5M | +29.7% |
| Pre-tax Income | $209.5M | +128.0% |
| Income Tax | $56.1M | +134.6% |
| Net Income | $153.4M | +125.7% |
| EPS (Basic) | $1.05 | +133.3% |
| EPS (Diluted) | $1.04 | +131.1% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $164.0M | -41.1% |
| Accounts Receivable | $49.9M | -13.4% |
| Inventory | $223.7M | +1.2% |
| Current Assets | $471.4M | -19.1% |
| Total Assets | $2.17B | -8.4% |
| Current Liabilities | $217.0M | +11.2% |
| Long-term Debt | $440.0M | -25.9% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $224.5M | -38.1% |
| Capital Expenditures | $77.1M | -12.9% |
| Investing Cash Flow | $49.1M | +155.5% |
| Financing Cash Flow | -$387.9M | -232.9% |
| Free Cash Flow | $147.3M | -46.2% |
| Total Liabilities |
| $810.8M |
| -13.4% |
| Stockholders' Equity | $1.36B | -5.1% |